Form D · Biotechnology
Zephyr AI, Inc.
Mc Lean, VA · CIK 0001915384
Offering snapshot reported Mar 13, 2024 · SEC filing
- Reported sold
- $111M Offering amount: $121M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 27, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 13, 2024 | Initial | $111,354,487 | No comparison | 30 | SEC filing |
| Apr 4, 2022 | Initial | $18,359,789 | No comparison | 31 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-507477
Source: Form D, filed Mar 13, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sol Barer | Director |
| Rachael Brake | Executive |
| Yisroel Brumer | Director |
| Roger Ferguson, Jr. | Director |
| David Morgan | Executive |
| Steve Murray | Director |
| Rob Myers | Executive |
| Jack Rowe | Director |
| Ken Samet | Director |
| Jeff Sherman | Executive |
| Moncef Slaoui | Director |
| John Tiernan | Executive |
| Grant Verstandig | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1800 Tysons Blvd, Suite 901
Mc Lean, VA, 22102
Mc Lean, VA, 22102